Baird Ups Fisher Scientific to Outperform

Cites the company's third quarter results

Robert W. Baird upgraded Fisher Scientific (FSH ) to outperform from neutral, citing the company's "solid" third quarter results.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.